Sweden · Delayed Price · Currency is SEK CTI BioPharma Statistics
Total Valuation
Epiroc AB has a market cap or net worth of SEK 228.23 billion. The enterprise value is 240.59 billion.
| Market Cap | 228.23B |
| Enterprise Value | 240.59B |
Important Dates
The last earnings date was Friday, July 18, 2025.
| Earnings Date | Jul 18, 2025 |
| Ex-Dividend Date | Oct 13, 2025 |
Share Statistics
Epiroc AB has 1.21 billion shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 819.01M |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 49.79% |
| Float | 1.00B |
Valuation Ratios
The trailing PE ratio is 26.41 and the forward PE ratio is 24.20. Epiroc AB's PEG ratio is 3.97.
| PE Ratio | 26.41 |
| Forward PE | 24.20 |
| PS Ratio | 3.59 |
| PB Ratio | 5.91 |
| P/TBV Ratio | 14.06 |
| P/FCF Ratio | 22.57 |
| P/OCF Ratio | 20.46 |
| PEG Ratio | 3.97 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.82, with an EV/FCF ratio of 23.79.
| EV / Earnings | 26.79 |
| EV / Sales | 3.78 |
| EV / EBITDA | 15.82 |
| EV / EBIT | 19.46 |
| EV / FCF | 23.79 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.55.
| Current Ratio | 2.04 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 2.11 |
| Interest Coverage | 9.72 |
Financial Efficiency
Return on equity (ROE) is 23.47% and return on invested capital (ROIC) is 12.84%.
| Return on Equity (ROE) | 23.47% |
| Return on Assets (ROA) | 9.65% |
| Return on Invested Capital (ROIC) | 12.84% |
| Return on Capital Employed (ROCE) | 21.48% |
| Revenue Per Employee | 3.33M |
| Profits Per Employee | 470,597 |
| Employee Count | 18,874 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, Epiroc AB has paid 2.72 billion in taxes.
| Income Tax | 2.72B |
| Effective Tax Rate | 23.20% |
Stock Price Statistics
The stock price has decreased by -0.22% in the last 52 weeks. The beta is 0.93, so Epiroc AB's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -0.22% |
| 50-Day Moving Average | 210.73 |
| 200-Day Moving Average | 207.29 |
| Relative Strength Index (RSI) | 33.59 |
| Average Volume (20 Days) | 881,891 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Epiroc AB had revenue of SEK 63.62 billion and earned 8.98 billion in profits. Earnings per share was 7.43.
| Revenue | 63.62B |
| Gross Profit | 23.63B |
| Operating Income | 12.39B |
| Pretax Income | 11.72B |
| Net Income | 8.98B |
| EBITDA | 14.50B |
| EBIT | 12.39B |
| Earnings Per Share (EPS) | 7.43 |
Balance Sheet
The company has 9.00 billion in cash and 21.35 billion in debt, giving a net cash position of -12.34 billion or -10.21 per share.
| Cash & Cash Equivalents | 9.00B |
| Total Debt | 21.35B |
| Net Cash | -12.34B |
| Net Cash Per Share | -10.21 |
| Equity (Book Value) | 38.60B |
| Book Value Per Share | 31.91 |
| Working Capital | 22.65B |
Cash Flow
In the last 12 months, operating cash flow was 11.16 billion and capital expenditures -1.04 billion, giving a free cash flow of 10.11 billion.
| Operating Cash Flow | 11.16B |
| Capital Expenditures | -1.04B |
| Free Cash Flow | 10.11B |
| FCF Per Share | 8.36 |
Margins
Gross margin is 37.14%, with operating and profit margins of 19.47% and 14.11%.
| Gross Margin | 37.14% |
| Operating Margin | 19.47% |
| Pretax Margin | 18.42% |
| Profit Margin | 14.11% |
| EBITDA Margin | 22.80% |
| EBIT Margin | 19.47% |
| FCF Margin | 15.89% |
Dividends & Yields
This stock pays an annual dividend of 3.80, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 3.80 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 51.16% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 1.75% |
| Earnings Yield | 3.93% |
| FCF Yield | 4.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Epiroc AB has an Altman Z-Score of 5.85 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.85 |
| Piotroski F-Score | 7 |